BioAge Labs, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BIOA

organization

Jurisdiction: US-DELegal Form: XTIQ

ACTIVE

LEI: 529900NG0C40250Z7875SIC: 2834

Also known as: BioAge Labs, Inc.

SEC Insider

$55.0M

106 transactions

Summary

BioAge Labs, Inc. (BIOA) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $47.9MSales: $6.2M15 insiders

Date	Insider	Type	Value
2026-04-01	RUBIN PAUL D(Chief Medical Officer)	Sell	$157K
2026-03-02	RUBIN PAUL D(Chief Medical Officer)	Sell	$151K
2026-04-01	RUBIN PAUL D(Chief Medical Officer)	M	$22K
2026-03-02	RUBIN PAUL D(Chief Medical Officer)	M	$22K
2026-04-01	RUBIN PAUL D(Chief Medical Officer)	M	$22K
2026-04-23	GOLDSTEIN DOV A MD(Chief Financial Officer)	M	$16K
2026-03-01	GOLDSTEIN DOV A MD(Chief Financial Officer)	M	$16K
2026-03-02	RUBIN PAUL D(Chief Medical Officer)	M	$13K
2026-06-10	GARNIER JEAN PIERRE	A	$0
2026-06-10	HEALY JAMES	A	$0
2026-06-10	ENRIGHT PATRICK G	A	$0
2026-06-10	Davidson Michael H.	A	$0
2026-06-10	Hemrajani Rekha	A	$0
2026-06-10	Pande Vijay Satyanand	A	$0
2026-04-23	GOLDSTEIN DOV A MD(Chief Financial Officer)	M	$0
2026-04-01	RUBIN PAUL D(Chief Medical Officer)	M	$0
2026-04-01	RUBIN PAUL D(Chief Medical Officer)	M	$0
2026-03-02	RUBIN PAUL D(Chief Medical Officer)	M	$0
2026-03-02	RUBIN PAUL D(Chief Medical Officer)	M	$0
2026-03-01	GOLDSTEIN DOV A MD(Chief Financial Officer)	M	$0

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

BioAge Labs, Inc. — Contributions, Lobbying & Contracts | Poliscope